Adam B. Weiner, MD
@adam_weiner535
@CedarsSinai + @UclaUrology @UroOnc ♋️🧬|Supporting editor @EUplatinum📝|Formerly: @NM_Urology @Uchipritzker @Yale ‘12| @abhita_reddy=No one can do it better❤️
ID: 23269670
https://www.ncbi.nlm.nih.gov/myncbi/12AgCapNreHQ4/bibliography/public/ 08-03-2009 03:12:17
2,2K Tweet
2,2K Takipçi
1,1K Takip Edilen
🚨New Publication🚨 -12.8% iPCa, 4.4% >GG2 (n=811) -PHI >55 associated with iPCa -Pre op PIRADS 4-5, neg biopsy with 95% NPV for iPCa -Most iPCa is low volume GG1 managed with active surveillance, n=3 further PCa treatment doi.org/10.1002/pros.2… Amy Krambeck NM Urology
🚨 Ex vivo screening with patient-derived organoids for #bladdercancer🚨 Just out in European Urology 🔬A step forward in precision oncology 🧬Individualizing care for patients based on ex vivo drug sensitivity 👏Aaron Udager, MD, PhD U-M Rogel Cancer Center 🔗tinyurl.com/yc6h5f3r
Too many reasons to choose urology! 1) Great surgeries 😷 2) opportunities to teach 👨🏫 3) fulfilling pt interactions 🤝 And who doesn’t love a simple prostatectomy? Amer. Urol. Assn. NM Urology UCLA Urology Urology Graduate Medical Education at Cedars-Sinai #urosome
🚨Olaparib for high-risk Biochemically Recurrent #ProstateCancer🚨 JAMA Oncology ✅51 pts w/ BCR after prostatectomy (PSADT<6mo) 💊Olaparib monotheray, NO ADT!!!! 50% PSA decline: 👉Nearly half of pts w/ HRR alterations 👉All pts w/ BCRA2 alterations had a PSA50 response
Recently published: The Proteogenomics of #ProstateCancer #Radioresistance, by Roni Haas et al. bit.ly/3MjpkhY Beth Neilsen Danny Vesprini Amar Kishan Melvin LK CHUA Thomas Kislinger #openaccess
We've had no data on real-world EV+P use for mUC, until now. In European Urology we show rapid dissemination of EV+P in practice. As of 3/31/24, <4 mo after U.S. FDA full approval, EV+P accounted for ~50% of 1L tx starts, supplanting platinum-chemo (23%). authors.elsevier.com/a/1jeFg14kplyy…
🚨Suicide Attempt & Suicide Death Among Spouses of Patients with Cancer🚨 JAMA Oncology 👉Danish study of >400k spouses of patients w/ cancer Higher risk of both: 1⃣Suicide attempts (HR 1.28) & 2⃣Suicide deaths (HR 1.47) 🛑A poignant reminder for those treating cancer of the
Where our patients live and characteristics of their community play an important role in the experience of cancer-related financial hardship. Really enjoyed working on this project with Michigan Urology chief resident and future YUO Urology@UNC fellow Apoorv Dhir.
Wonderful morning seeing Edward Schaeffer, MD, PhD at Urology Graduate Medical Education at Cedars-Sinai grand rounds discussing TP biopsy for #prostatecancer 👏 👀Great data forthcoming from the PREVENT trial Hyung Kim Jim Hu NM Urology Michael Ahdoot MD Timothy Daskivich Peris Castañeda, MD Jasmine Lin Cedars-Sinai Academic Medicine
🚨Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant #ProstateCancer JAMA Network Open Cohort study, pts w/ nmCRPC n=870 Compared with Apa and Enza, Darolutamide a/w... 1⃣Longer time on therapy 2⃣Longer time to metastatic progression 3⃣Fewer
Department Chair, Edward Schaeffer, MD, PhD, MD, PhD, stopped by Urology Graduate Medical Education at Cedars-Sinai grand rounds to discuss TP biopsy for #prostatecancer 👏 📸: Adam B. Weiner, MD, MD
🙂Welcome to #ProstateCancerAwarenessMonth! It's a great time to remind friends & loved ones to consider screening🧪 #PCAM ZERO Prostate Cancer PCF Science Prostate Cancer Foundation Urology Care Foundation Amer. Urol. Assn. YUO Society of Urologic Oncology Cedars-Sinai Academic Medicine Cedars-Sinai Urology Graduate Medical Education at Cedars-Sinai UCLA Urology NM Urology
Barriers to clinical trials participation are often rooted in social determinants of health. But what matters more, characteristics of the individual or the community they reside in? Lindsey Herrel Kristian Stensland, MD MPH Avi Maganty MD Nat’l Clinician Scholars Program at U-M IHPI U-M IHPI Michigan Urology ascopubs.org/doi/10.1200/OP…
🔍 Let's bust some myths! In today's Urology Mythbusters, we clear up common misconceptions and bring you the truth. 💡 This episode features Justin Dubin, MD & Rachel S. Rubin, MD #UrologyMythbusters #Urology
Did you know half the men over the age of 40 have experienced sexual dysfunction? 🍆 Thank you Raevti Bole, MD for talking about #SexualHealthAwarenessMonth, and helping us break the stigma around talking about your sexual health. Click the link to learn more ➡️ bit.ly/3ZbDslj